Human papillomavirus vaccines for cervical cancer prevention: translating possibility into reality
- PMID: 23104325
- PMCID: PMC3529599
- DOI: 10.1093/jnci/djs453
Human papillomavirus vaccines for cervical cancer prevention: translating possibility into reality
Figures
Comment on
-
Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model-based analysis.J Natl Cancer Inst. 2012 Nov 21;104(22):1712-23. doi: 10.1093/jnci/djs395. Epub 2012 Oct 27. J Natl Cancer Inst. 2012. PMID: 23104323
References
-
- Van de Velde N, Boily M-C, Drolet M, et al. Population-level impact of the bivalent, quadrivalent, and candidate nonavalent human papillomavirus vaccines: a comparative model-based analysis J Natl Cancer Inst 2012; 104(22):forthcoming - PubMed
-
- Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer. 2010. 127(12):2893–2917 - PubMed
-
- Tomori O. From smallpox eradication to the future of global health: innovations, application and lessons for future eradication and control initiatives Vaccine. 2011. 29(suppl 4):D145–D148 - PubMed
-
- Chang MH, You SL, Chen CJ, et al. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study J Natl Cancer Inst. 2009. 101(19):1348–1355 - PubMed
-
- Munoz N, Kjaer SK, Sigurdsson K, et al. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women J Natl Cancer Inst. 2010. 102(5):325–339 - PubMed
